Becker Hewes - Chief Medical Officer, Blueprint Medicines Corp

As of September 17, 2021


Becker Hewes Net Worth

  • Net worth is estimated to be at least $4.21M
  • Owns at least 26,187 units of Blueprint Medicines Corp stock
  • Sold an estimated value of $1.31M in the last 7 months at Blueprint Medicines Corp

Becker Hewes Trading

  • Largest purchase of shares was 8,750 units , worth over $579.6K on September 17, 2021
  • Largest sale of shares was 11,833 units , worth over $1.2M on September 17, 2021
  • In total has made about 3 transactions over 7 months
  • Usually trades in September, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Blueprint Medicines Corp Executive Compensation

Name
Year
Salary
Total
Jeffrey W. Albers 2020 $645,000 $6,344,667
Jeffrey W. Albers 2019 $590,000 $9,362,371
Jeffrey W. Albers 2018 $541,144 $9,740,799
Michael Landsittel 2020 $379,575 $2,014,974
Michael Landsittel 2019 $345,000 $1,958,720
Michael Landsittel 2018 $281,678 $1,740,610
Fouad Namouni, M.D. 2020 $186,154 $6,668,732
Fouad Namouni, M.D. 2019 - -
Fouad Namouni, M.D. 2018 - -
Kathryn Haviland 2020 $460,944 $2,363,556
Kathryn Haviland 2019 $431,830 $3,090,423
Kathryn Haviland 2018 $392,589 $2,601,762
Tracey L. McCain, Esq. 2020 $453,301 $2,346,428
Tracey L. McCain, Esq. 2019 $437,972 $2,900,568
Tracey L. McCain, Esq. 2018 $425,216 $2,647,962
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1597264/000155837021004557/tmb-20210602xdef14a.htm

Blueprint Medicines Corp Insider Trading

  • The most recent transaction was 3,241 units sold on October 7, 2021 by Fouad Namouni worth over $318.2K
  • In the last 6 years, insiders at Blueprint Medicines Corp sold an estimated value of $157.77M and bought an estimated value of $14.93M
  • The most active traders are Jeffrey Albers, CEO and President,  Kate Haviland, Chief Operating Officer,  and Ariel Hurley, Principal Accounting Officer
  • Insider trading is most common in June, with the busiest year in 2020

Blueprint Medicines Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1